Concepedia

Author

Ann Aurell Holmberg

AstraZeneca (Sweden)

Also Known As

A Aurell Holmberg, A HOLMBERG, Ann A. Holmberg, Ann Aurell Holmberg

18

Publications

160

Citations

7

H-Index

15

Concepts

All Affiliations

AstraZeneca (Sweden)Uppsala University
AA

About

Ann Aurell Holmberg is an author at AstraZeneca (Sweden) specializing in medicine, gastrointestinal pharmacology, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

29

2

Pharmacology

2

2

29

3

Anesthesia

1

1

11

4

Biochemistry

1

1

18

5

Gastroenterology

1

1

11

Ann Aurell Holmberg

×

5

Publications

123

Citations

5

H-Index

YearCitations

(R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action

Anders Lehmann, Madeleine Antonsson, Ann Aurell Holmberg,

Journal of Pharmacology and Experimental Therapeutics

2009

55

Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma

Magnus Nilsson, Magdalena Rhedin, Ramon Hendrickx,

Drug Design Development and Therapy

2022

26

Application of a combined effect compartment and binding model for gastric acid inhibition of AR-HO47108: A potassium competitive acid blocker, and its active metabolite AR-HO47116 in the dog

Angela Äbelö, Magdalena Andersson, Ann Aurell Holmberg,

European Journal of Pharmaceutical Sciences

2006

18

Systemic Exposure to the Metabolites of Lesogaberan in Humans and Animals: A Case Study of Metabolites in Safety Testing

Ann Aurell Holmberg, Anja Ekdahl, Lars Weidolf

Drug Metabolism and Disposition

2014

13

Effects of (2<i>R</i>)‐(3‐amino‐2‐fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice

Anders Lehmann, Ann Aurell Holmberg, Ulhas Bhatt,

British Journal of Pharmacology

2005

11

Page 1